ClinicalTrials.gov
public full text
Public Domain
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis
This study is a randomized controlled phase I clinical study with safety, efficacy, and pharmacokinetic/pharmacodynamic characteristics in patients with rheumatoid arthritis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis#1072348
- A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis#1058537
- An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy#846755
- The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients#885880
- Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)#979589
Record · ID 913610
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive